124 related articles for article (PubMed ID: 16011834)
1. Effects of the cyclin-dependent kinase inhibitor CYC202 (R-roscovitine) on the physiology of cultured human keratinocytes.
Atanasova G; Jans R; Zhelev N; Mitev V; Poumay Y
Biochem Pharmacol; 2005 Sep; 70(6):824-36. PubMed ID: 16011834
[TBL] [Abstract][Full Text] [Related]
2. The Cyclin-dependent kinase inhibitor CYC202 (R-roscovitine) inhibits retinoblastoma protein phosphorylation, causes loss of Cyclin D1, and activates the mitogen-activated protein kinase pathway.
Whittaker SR; Walton MI; Garrett MD; Workman P
Cancer Res; 2004 Jan; 64(1):262-72. PubMed ID: 14729633
[TBL] [Abstract][Full Text] [Related]
3. Effects of the CDK-inhibitor CYC202 on p38 MAPK, ERK1/2 and c-Myc activities in papillomavirus type 16 E6- and E7-transformed human keratinocytes.
Atanasova GN; Isaeva AR; Zhelev N; Poumay Y; Mitev VI
Oncol Rep; 2007 Oct; 18(4):999-1005. PubMed ID: 17786366
[TBL] [Abstract][Full Text] [Related]
4. In vitro and in vivo pharmacokinetic-pharmacodynamic relationships for the trisubstituted aminopurine cyclin-dependent kinase inhibitors olomoucine, bohemine and CYC202.
Raynaud FI; Whittaker SR; Fischer PM; McClue S; Walton MI; Barrie SE; Garrett MD; Rogers P; Clarke SJ; Kelland LR; Valenti M; Brunton L; Eccles S; Lane DP; Workman P
Clin Cancer Res; 2005 Jul; 11(13):4875-87. PubMed ID: 16000586
[TBL] [Abstract][Full Text] [Related]
5. In vitro and in vivo antitumor properties of the cyclin dependent kinase inhibitor CYC202 (R-roscovitine).
McClue SJ; Blake D; Clarke R; Cowan A; Cummings L; Fischer PM; MacKenzie M; Melville J; Stewart K; Wang S; Zhelev N; Zheleva D; Lane DP
Int J Cancer; 2002 Dec; 102(5):463-8. PubMed ID: 12432547
[TBL] [Abstract][Full Text] [Related]
6. Roscovitine, olomoucine, purvalanol: inducers of apoptosis in maturing cerebellar granule neurons.
Monaco EA; Beaman-Hall CM; Mathur A; Vallano ML
Biochem Pharmacol; 2004 May; 67(10):1947-64. PubMed ID: 15130771
[TBL] [Abstract][Full Text] [Related]
7. The lethal effects of pharmacological cyclin-dependent kinase inhibitors in human leukemia cells proceed through a phosphatidylinositol 3-kinase/Akt-dependent process.
Yu C; Rahmani M; Dai Y; Conrad D; Krystal G; Dent P; Grant S
Cancer Res; 2003 Apr; 63(8):1822-33. PubMed ID: 12702569
[TBL] [Abstract][Full Text] [Related]
8. Cholesterol depletion upregulates involucrin expression in epidermal keratinocytes through activation of p38.
Jans R; Atanasova G; Jadot M; Poumay Y
J Invest Dermatol; 2004 Sep; 123(3):564-73. PubMed ID: 15304097
[TBL] [Abstract][Full Text] [Related]
9. In vitro activity of cyclin-dependent kinase inhibitor CYC202 (Seliciclib, R-roscovitine) in mantle cell lymphomas.
Lacrima K; Valentini A; Lambertini C; Taborelli M; Rinaldi A; Zucca E; Catapano C; Cavalli F; Gianella-Borradori A; Maccallum DE; Bertoni F
Ann Oncol; 2005 Jul; 16(7):1169-76. PubMed ID: 15851403
[TBL] [Abstract][Full Text] [Related]
10. Human keratinocytes respond to osmotic stress by p38 map kinase regulated induction of HSP70 and HSP27.
Garmyn M; Mammone T; Pupe A; Gan D; Declercq L; Maes D
J Invest Dermatol; 2001 Nov; 117(5):1290-5. PubMed ID: 11710946
[TBL] [Abstract][Full Text] [Related]
11. Ca(2+)/calmodulin-dependent protein kinase (CaM-kinase) inhibitor KN-62 suppresses the activity of mitogen-activated protein kinase (MAPK), c-myc activation and human keratinocyte proliferation.
Praskova M; Kalenderova S; Miteva L; Poumay Y; Mitev V
Arch Dermatol Res; 2002 Jul; 294(4):198-202. PubMed ID: 12111351
[TBL] [Abstract][Full Text] [Related]
12. Ultraviolet B-mediated phosphorylation of the small heat shock protein HSP27 in human keratinocytes.
Wong JW; Shi B; Farboud B; McClaren M; Shibamoto T; Cross CE; Isseroff RR
J Invest Dermatol; 2000 Sep; 115(3):427-34. PubMed ID: 10951279
[TBL] [Abstract][Full Text] [Related]
13. A novel CDK inhibitor, CYC202 (R-roscovitine), overcomes the defect in p53-dependent apoptosis in B-CLL by down-regulation of genes involved in transcription regulation and survival.
Alvi AJ; Austen B; Weston VJ; Fegan C; MacCallum D; Gianella-Borradori A; Lane DP; Hubank M; Powell JE; Wei W; Taylor AM; Moss PA; Stankovic T
Blood; 2005 Jun; 105(11):4484-91. PubMed ID: 15692065
[TBL] [Abstract][Full Text] [Related]
14. CR8, a potent and selective, roscovitine-derived inhibitor of cyclin-dependent kinases.
Bettayeb K; Oumata N; Echalier A; Ferandin Y; Endicott JA; Galons H; Meijer L
Oncogene; 2008 Oct; 27(44):5797-807. PubMed ID: 18574471
[TBL] [Abstract][Full Text] [Related]
15. Cyclin-dependent kinase inhibitor Roscovitine induces apoptosis in chronic lymphocytic leukemia cells.
Hahntow IN; Schneller F; Oelsner M; Weick K; Ringshausen I; Fend F; Peschel C; Decker T
Leukemia; 2004 Apr; 18(4):747-55. PubMed ID: 14973497
[TBL] [Abstract][Full Text] [Related]
16. The small heat-shock protein Hsp27 undergoes ERK-dependent phosphorylation and redistribution to the cytoskeleton in response to dual leucine zipper-bearing kinase expression.
Robitaille H; Simard-Bisson C; Larouche D; Tanguay RM; Blouin R; Germain L
J Invest Dermatol; 2010 Jan; 130(1):74-85. PubMed ID: 19675578
[TBL] [Abstract][Full Text] [Related]
17. UVB-mediated activation of p38 mitogen-activated protein kinase enhances resistance of normal human keratinocytes to apoptosis by stabilizing cytoplasmic p53.
Chouinard N; Valerie K; Rouabhia M; Huot J
Biochem J; 2002 Jul; 365(Pt 1):133-45. PubMed ID: 12071847
[TBL] [Abstract][Full Text] [Related]
18. Dual role of protein kinase C on mitogen-activated protein kinase activation and human keratinocyte proliferation.
Praskova M; Kalenderova S; Miteva L; Poumay Y; Mitev V
Exp Dermatol; 2002 Aug; 11(4):344-8. PubMed ID: 12190943
[TBL] [Abstract][Full Text] [Related]
19. Cytokine regulation by MAPK activated kinase 2 in keratinocytes exposed to sulfur mustard.
Yego EC; Dillman JF
Toxicol In Vitro; 2013 Oct; 27(7):2067-75. PubMed ID: 23851002
[TBL] [Abstract][Full Text] [Related]
20. In situ demonstration of phosphorylated c-jun and p38 MAP kinase in epidermal keratinocytes following ultraviolet B irradiation of human skin.
Pfundt R; van Vlijmen-Willems I; Bergers M; Wingens M; Cloin W; Schalkwijk J
J Pathol; 2001 Feb; 193(2):248-55. PubMed ID: 11180173
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
